These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22385249)

  • 21. Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during
    Garand M; Goodier M; Owolabi O; Donkor S; Kampmann B; Sutherland JS
    Front Immunol; 2018; 9():257. PubMed ID: 29520269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
    Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
    Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ expression of CD40, CD40L (CD154), IL-12, TNF-alpha, IFN-gamma and TGF-beta1 in murine lungs during slowly progressive primary tuberculosis.
    Mogga SJ; Mustafa T; Sviland L; Nilsen R
    Scand J Immunol; 2003 Sep; 58(3):327-34. PubMed ID: 12950679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.
    Morais-Papini TF; Coelho-Dos-Reis JGA; Wendling APB; do Vale Antonelli LR; Wowk PF; Bonato VLD; Augusto VM; Elói-Santos S; Martins-Filho OA; Carneiro CM; Teixeira-Carvalho A
    Immunobiology; 2017 Nov; 222(11):1014-1024. PubMed ID: 28619539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.
    Kumar NP; Sridhar R; Nair D; Banurekha VV; Nutman TB; Babu S
    Immunology; 2015 Apr; 144(4):677-86. PubMed ID: 25363329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione levels and immune responses in tuberculosis patients.
    Venketaraman V; Millman A; Salman M; Swaminathan S; Goetz M; Lardizabal A; David Hom ; Connell ND
    Microb Pathog; 2008 Mar; 44(3):255-61. PubMed ID: 17959342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects.
    Silver RF; Li Q; Boom WH; Ellner JJ
    J Immunol; 1998 Mar; 160(5):2408-17. PubMed ID: 9498784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells.
    Sharapova TN; Ivanova OK; Prasolov VS; Romanova EA; Sashchenko LP; Yashin DV
    IUBMB Life; 2017 Dec; 69(12):971-977. PubMed ID: 29083508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
    Ramana Rao PV; Rajasekaran S; Raja A
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tim-3 pathway affects NK cell impairment in patients with active tuberculosis.
    Wang F; Hou H; Wu S; Tang Q; Huang M; Yin B; Huang J; Liu W; Mao L; Lu Y; Sun Z
    Cytokine; 2015 Dec; 76(2):270-279. PubMed ID: 26050547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection.
    Paidipally P; Tripathi D; Van A; Radhakrishnan RK; Dhiman R; Venkatasubramanian S; Devalraju KP; Tvinnereim AR; Valluri VL; Vankayalapati R
    J Infect Dis; 2018 Mar; 217(8):1323-1333. PubMed ID: 29390153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.
    Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S
    Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection.
    Parasa VR; Sikhamani R; Raja A
    PLoS One; 2012; 7(6):e37448. PubMed ID: 22715368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.
    Feng CG; Kaviratne M; Rothfuchs AG; Cheever A; Hieny S; Young HA; Wynn TA; Sher A
    J Immunol; 2006 Nov; 177(10):7086-93. PubMed ID: 17082625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione.
    Allen M; Bailey C; Cahatol I; Dodge L; Yim J; Kassissa C; Luong J; Kasko S; Pandya S; Venketaraman V
    Front Immunol; 2015; 6():508. PubMed ID: 26500648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D.
    Ma Y; Gong J; Liu Y; Guo W; Jin B; Wang X; Chen L
    Life Sci; 2016 Apr; 151():174-181. PubMed ID: 26968781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity.
    Abate G; Spencer CT; Hamzabegovic F; Blazevic A; Xia M; Hoft DF
    Infect Immun; 2016 Feb; 84(2):580-9. PubMed ID: 26644385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
    Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R
    Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.